Similar articles

• Strengthening Howick's argument against the alleged superiority of placebo-controlled trials.

  Rennie S, Stürmer T. Rennie S, et al. Am J Bioeth. 2009 Sep;9(9):62-4. doi: 10.1080/15265160903090082. Am J Bioeth. 2009. PMID: 19998200 No abstract available.
• Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution.

  Golomb BA. Golomb BA. Am J Bioeth. 2009 Sep;9(9):67-9. doi: 10.1080/15265160903098424. Am J Bioeth. 2009. PMID: 19998203 No abstract available.
• Conflating scientific with clinical considerations.

  van der Graaf R, van Delden JJ. van der Graaf R, et al. Am J Bioeth. 2009 Sep;9(9):58-9. doi: 10.1080/15265160903098598. Am J Bioeth. 2009. PMID: 19998198 No abstract available.
• When do the federal regulations allow placebo-controlled trials in children?

  Miller FG, Wendler D, Wilfond B. Miller FG, et al. J Pediatr. 2003 Feb;142(2):102-7. doi: 10.1067/mpd.2003.43. J Pediatr. 2003. PMID: 12584527 Review. No abstract available.
• Historical control monotherapy design in the treatment of epilepsy.

  French JA, Wang S, Warnock B, Temkin N. French JA, et al. Epilepsia. 2010 Oct;51(10):1936-43. doi: 10.1111/j.1528-1167.2010.02650.x. Epilepsia. 2010. PMID: 20561024 Review.